2020 annual financial data
Fulcrum Therapeutics 2020 Operating margin
Fulcrum Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -811.64%.
Operating income was -71,611,000 USD and net income was -68,440,000 USD.
Operating cash flow was -53,655,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,823,000 USD
- Operating income
- -71,611,000 USD
- Net income
- -68,440,000 USD
- Operating cash flow
- -53,655,000 USD